Table 4.
Characteristic | Cox Univariate | Cox Multivariate | ||||
---|---|---|---|---|---|---|
HR (95% CI) | P–value | HR (95% CI) | P–value | HR (95% CI) | P–value | |
Galectin–3 (> 8.65 versus ≤8.65 ng/ml) | 2.47 (1.25–4.87) | P < 0.01 | 2.13 (1.07–4.26) | 0.03 | – | – |
Galectin–3 (continuous variable) | 1.01 (0.97–1.05) | 0.61 | – | – | 1.01 (0.98–1.05) | 0.49 |
Age (years) | 1.06 (1.05–1.08) | P < 0.01 | 1.05 (1.03–1.07) | P < 0.01 | 1.05 (1.04–1.07) | P < 0.01 |
ESRD due to diabetes (yes versus no) | 2.66 (1.86–3.80) | P < 0.01 | 2.52 (1.35–4.72) | P < 0.01 | 2.43 (1.30–4.53) | P < 0.01 |
ESRD due to glomerulonephritis (yes versus no) | 0.35 (0.23–0.54) | P < 0.01 | ||||
ESRD due to hypertension (yes versus no) | 1.53 (1.02–2.30) | 0.04 | 2.01 (1.04–3.88) | 0.04 | ||
Albumin (g/l) | 0.85 (0.80–0.90) | P < 0.01 | 0.91 (0.85–0.97) | P < 0.01 | 0.91 (0.85–0.97) | P < 0.01 |
Single–pool Kt/V | 0.38 (0.18–0.83) | 0.01 | 0.30 (0.12–0.72) | P < 0.01 | 0.29 (0.12–0.69) | P < 0.01 |
Alkaline phosphatase (u/l) | 1.003 (1.001–1.004) | 0.001 | 1.004 (1.002–1.005) | P < 0.01 | 1.004 (1.002–1.005) | P < 0.01 |
Sodium (mmol/l) | 0.92 (0.88–0.97) | P < 0.01 |
Abbreviations: CI confidence interval, ESRD end–stage renal disease, HR hazard ratio